Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
MATINAS BIOPHARMA
3145
MATINAS BIOPHARMA
Technology
Biotechnology
Health Care
Medical
Therapeutics
Matinas (OTCQB: MTNB) is identifying & developing safe/effective antifungal & anti-bacterial therapeutics for treatment of serious & life-threatening infections
Suggest edits
Founded
2011
Raised
$14.4M
Follow us
Companies in the same industry
AC Immune
ArGEN-X
CoDa Therapeutics, Inc.
Hengrui Therapeutics, Inc.
3-V Biosciences
Silverback Therapeutics
ApcinteX Limited
Anvajo
LifeMine Therapeutics
Cryofocus Biotech
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$4,400,000
Venture capital (Series A) - 2016
$10,000,000
Venture capital - 2015
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when MATINAS BIOPHARMA makes some noise.
